IKT Inhibikase Therapeutics, Inc. logo

IKT Inhibikase Therapeutics, Inc.

Healthcare
$1.69-2.87%ClosedMarket Cap: $120.0M

As of 2026-05-25

Analyst Consensus

Consensus

Buy

Target (Consensus)

$4.00

Target (Median)

$4.00

Target Range

$4.00 - $4.00

Upside from current price: 136.7%

Rating Distribution

1 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Dec 31$-0.49$500.0K5
Fri Dec 31$-0.48$500.0K3
Sun Dec 31$-0.42$36.7M2
Mon Dec 31$0.11$164.9M1